Guardant Health, Inc. (GH)
USD 32.36
(-7.12%)
USD 32.36
(-7.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -324.97 Million | -309.46 Million | -209.01 Million | -103.92 Million | -47.13 Million | -72.18 Million |
| Net Income | -479.44 Million | -654.58 Million | -384.77 Million | -246.28 Million | -67.85 Million | -84.26 Million |
| Depreciation & Amortization | 42.88 Million | 35.96 Million | 22.27 Million | 16.06 Million | 13.6 Million | 7.13 Million |
| Deferred income taxes | -86.61 Million | - | 12.89 Million | 11.16 Million | -1.59 Million | -769 Thousand |
| Stock-based compensation | 90.75 Million | 94.68 Million | 151.44 Million | 144.11 Million | 16.95 Million | 6.85 Million |
| Change in working capital | 53.84 Million | 61.56 Million | -40.46 Million | -47.66 Million | -6.09 Million | -1.12 Million |
| Other non-cash items | 53.61 Million | 152.91 Million | 29.6 Million | 18.67 Million | -2.15 Million | -13 Thousand |
| Investing Cash Flow | 840.25 Million | 149.81 Million | -63.15 Million | -617.08 Million | -317.57 Million | -153.02 Million |
| Investments in PPE | -20.48 Million | -77.46 Million | -75.03 Million | -54.05 Million | -21.28 Million | -20.2 Million |
| Acquisitions | - | -227.27 Million | -11.88 Million | 17.88 Million | -7.32 Million | 41 Million |
| Investment purchases | -635.49 Million | -327.72 Million | -940.23 Million | -1.12 Billion | -614.29 Million | -287.45 Million |
| Sales/Maturities of investments | 1.49 Billion | 555 Million | 952.11 Million | 562.54 Million | 325.33 Million | 154.62 Million |
| Other Investing Activities | 1.53 Million | 227.27 Million | 11.88 Million | -17.88 Million | -68 Thousand | -132.82 Million |
| Financing Cash Flow | 477.37 Million | -189.09 Million | -66.82 Million | 1.41 Billion | 367.3 Million | 293.16 Million |
| Debt repayment | - | -71 Thousand | -930 Thousand | -174 Thousand | -127 Thousand | -443 Thousand |
| Dividends payments | - | - | - | - | - | -3.15 Million |
| Common Stock Repurchased | -11.19 Million | -7.87 Million | -83.75 Million | 7.09 Million | - | -172 Thousand |
| Common Stock Issuance | 482.54 Million | 11.94 Million | 17.86 Million | 355.73 Million | 367.74 Million | 254 Million |
| Other Financing Activities | -5.16 Million | -200.96 Million | -83.75 Million | 1.05 Billion | 367.43 Million | 42.92 Million |
| Accounts receivables | 8.37 Million | 375 Thousand | -44.35 Million | -5.46 Million | -7.38 Million | -22.9 Million |
| Accounts payables | 88.59 Million | 60.32 Million | 8.63 Million | -7.85 Million | 4.34 Million | 5.04 Million |
| Inventory | -10.35 Million | -20.92 Million | -7.95 Million | -7.53 Million | -6.04 Million | -1.84 Million |
| Other working capital | -32.77 Million | 21.78 Million | 3.2 Million | -26.8 Million | 3 Million | 18.57 Million |
| Cash at beginning of period | 141.64 Million | 492.28 Million | 832.97 Million | 143.22 Million | 140.54 Million | 72.59 Million |
| Cash at end of period | 1.13 Billion | -350.34 Million | 492.28 Million | 832.97 Million | 143.22 Million | 140.54 Million |
| Capital Expenditure | -20.48 Million | -77.46 Million | -75.03 Million | -54.05 Million | -21.28 Million | -20.2 Million |
| Effect of forex changes on cash | -911 Thousand | -1.6 Million | -1.69 Million | 455 Thousand | 84 Thousand | - |
| Net cash flow / Change in cash | 991.89 Million | -842.62 Million | -340.68 Million | 689.74 Million | 2.68 Million | 67.94 Million |
| Free Cash Flow | -345.46 Million | -386.92 Million | -284.05 Million | -157.98 Million | -68.41 Million | -92.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -102.62 Million | -114.98 Million | -187.04 Million | -479.44 Million | -86.1 Million | -72.77 Million |
| Depreciation & Amortization | 10.7 Million | 10.71 Million | 10.86 Million | 42.88 Million | 11.03 Million | 10.63 Million |
| Deferred income taxes | - | - | 66.96 Million | -86.61 Million | -24.46 Million | -42.5 Million |
| Stock-based compensation | 27.23 Million | 27.04 Million | 24.32 Million | 90.75 Million | 21.81 Million | 22.35 Million |
| Change in working capital | -53.69 Million | 7.86 Million | 64.17 Million | 53.84 Million | -8.39 Million | -20.14 Million |
| Other non-cash items | 121.23 Million | 71.12 Million | -58.01 Million | 53.61 Million | 8.3 Million | 8.42 Million |
| Investing Cash Flow | -5.07 Million | 28.06 Million | 663.45 Million | 840.25 Million | 260.69 Million | -241.12 Million |
| Investments in PPE | -5.07 Million | -6.93 Million | -4.07 Million | -20.48 Million | -2.37 Million | -6.51 Million |
| Acquisitions | - | - | - | - | -263.07 Million | 234.61 Million |
| Investment purchases | - | - | - | -635.49 Million | -72.92 Million | -499.31 Million |
| Sales/Maturities of investments | - | 35 Million | 666 Million | 1.49 Billion | 336 Million | 264.7 Million |
| Other Investing Activities | - | 35 Million | 1.53 Million | 1.53 Million | 263.07 Million | -234.61 Million |
| Financing Cash Flow | 5.89 Million | -1.07 Million | 90.56 Million | 477.37 Million | 3.8 Million | 383.85 Million |
| Debt repayment | - | - | -37 Thousand | - | -37 Thousand | -19 Thousand |
| Dividends payments | - | - | -21.19 Million | - | - | - |
| Common Stock Repurchased | 7.21 Million | -1.54 Million | -3.08 Million | -11.19 Million | -3 Million | -4.11 Million |
| Common Stock Issuance | 9.57 Million | 213 Thousand | 93.53 Million | 482.54 Million | 7.56 Million | 381.29 Million |
| Other Financing Activities | -3.67 Million | -1.28 Million | -2.96 Million | -5.16 Million | -3.79 Million | 2.58 Million |
| Accounts receivables | -15.95 Million | 4.22 Million | 18 Thousand | 8.37 Million | -2.33 Million | -1.65 Million |
| Accounts payables | -28.26 Million | 13.24 Million | 62.01 Million | 88.59 Million | 1.22 Million | -2.52 Million |
| Inventory | -3.99 Million | -1.04 Million | 15.08 Million | -10.35 Million | -16.5 Million | -14.05 Million |
| Other working capital | -5.48 Million | -8.55 Million | -12.94 Million | -32.77 Million | 9.22 Million | -1.91 Million |
| Cash at beginning of period | 1.12 Billion | 1.13 Billion | 457.33 Million | 141.64 Million | 271.17 Million | 223.71 Million |
| Cash at end of period | 1.03 Billion | 1.12 Billion | 1.13 Billion | 1.13 Billion | 457.36 Million | 271.17 Million |
| Capital Expenditure | -5.07 Million | -6.93 Million | -4.07 Million | -20.48 Million | -2.37 Million | -6.51 Million |
| Effect of forex changes on cash | -837 Thousand | -1.13 Million | 1.03 Million | -911 Thousand | -526 Thousand | -1.25 Million |
| Net cash flow / Change in cash | -94.01 Million | -4.28 Million | 676.19 Million | 991.89 Million | 186.18 Million | 47.46 Million |
| Free Cash Flow | -99.07 Million | -37.21 Million | -82.8 Million | -345.46 Million | -80.16 Million | -100.52 Million |
SLOFF
3839
0867
2395
AHH
CAF